The chemical diversity, binding specificity and propensity to interact with biological targets has inspired many researchers to utilize natural products as molecular probes. Almost all reported carbonic anhydrase inhibitors comprise a zinc binding group in their structure of which the primary sulfonamide moiety (-SO 2 NH 2 ) is the foremost example and to a lesser extent the primary sulfamate (-O-SO 2 NH 2 ) and sulfamide (-NH-SO 2 NH 2 ) groups. Natural products that comprise these zinc binding groups in their structure are however rare and relatively few natural products have been explored as a source for novel carbonic anhydrase inhibitors. This chapter will highlight the recent and growing interest in carbonic anhydrase inhibitors sourced from nature, demonstrating that natural product chemical space presents a rich source of potential alternate chemotypes for the discovery of novel drug-like carbonic anhydrase inhibitors.
Introduction
Carbonic anhydrases (CAs) are zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide to bicarbonate and a proton (1) . The active site zinc cation is the implied target for small molecule inhibitors to block the endogenous CA catalyzed reaction. Almost all reported CA inhibitors comprise a zinc binding group (ZBG) of which the primary sulfonamide moiety (-SO 2 NH 2 ) is the foremost example, and to a lesser extent the primary sulfamate (-O-SO 2 NH 2 ) and primary sulfamide (-NH-SO 2 NH 2 ) groups. Compounds sourced from nature that comprise either a primary sulfonamide, sulfamate or sulfamide moiety in their structure are exceedingly rare. A literature search of the Dictionary of Natural Products (DNP) database (2) (a comprehensive and fully-edited database on natural products (NPs)) revealed just two NP primary sulfonamide compounds, (-)-altemicidin 1 and psammaplin C 2, and five NP primary Streptomyces sioyaensis (9) . This compound exhibited potent acaricidal activity as well as strong inhibition of tumor cell growth (10) . A total synthesis of 1 as well as the isolation of two secondary sulfonamide analogues of 1 have subsequently been reported (9) . Psammaplin C 2 is a bromotyrosine amino acid derivative isolated from the marine sponge Pseudoceratina purpurea; (11, 12) no bioactivity for this alkaloid has been reported to date. The sulfamate nucleosides 3-7 were isolated from actinomycete species belonging to the genus Streptomyces.
These structurally related sulfamates are reported to have a range of biological effects including cytotoxicity, (4) herbicidal activity, (6) (7) (8) 13 ) inhibition of blood platelet aggregation,(5) antibacterial activity (5, 14) and antitrypanosomal activity (14) . Nucleocidin 3, isolated from the fermentation broth of Streptomyces calcus, is of particular note since it was the first NP to contain either a fluorinated carbohydrate or a primary sulfamate group. This molecule became an attractive synthetic target owing to its novel structural features, with the first total synthesis reported in 1976 (15) . Whilst NP 3 has been shown to exhibit broad spectrum antibacterial effects as well as potent antitrypanosomal activity, its potential use in the clinic has been limited due to toxicity (16) . The NPs 1-7 have not been investigated for CA inhibition properties, however it is likely that these compounds would inhibit CA activity owing to the presence of an unhindered primary sulfonamide or primary sulfamate moiety within their structure. Finally, our search of the DNP failed to identify any NP primary sulfamides. At the time of writing the Protein Data Bank (PDB) contained X-ray structures of ~160 sulfonamide ligands (R-SO 2 NH 2 ) in complex with hCA II (h = human NPs comprise a vast collection of diverse chemical structures and have proven to be an invaluable source of new chemotherapies (17) (18) (19) (20) (21) (22) . Plant NPs have been the basis of traditional medicine for thousands of years and continue to actively contribute to contemporary drug discovery (22) . In more recent times, marine macro-and micro-organisms along with terrestrial microbes have been the source of numerous lead molecules or drugs (23) . The significance of NPs in drug discovery is most evident in the anticancer and anti-infective therapeutic areas (24) (25) (26) (27) . For example, between 1940 and 2011 48.6% of all new anticancer small molecule therapies approved by the FDA were either NPs or NP derivatives (27) . Furthermore between 1981 and 2011 75% of all antibacterial new chemical entities were either NPs or their derivatives (27) . The success of NPs and their semi-synthetic derivatives as therapeutic agents is intrinsically linked to the fact that NPs have been biologically pre-validated and selected during evolution to bind to biosynthetic enzymes (28) (29) (30) (31) (32) (33) . It has been hypothesized that this inherent capacity to bind in biological space allows NPs to also recognize human therapeutic targets (28, 30, 33) . 
Natural products that inhibit carbonic anhydrase
Several classes of novel CA inhibitors have been identified from screening collections of NPs, most notable are coumarin and phenol containing NPs (36) . NPs comprising these fragments display diverse profiles of CA inhibition when compared to classical ZBGs and these will be discussed further in the following sections. In addition a selection of NP-derived CA inhibitors have been synthesized where the NP scaffold has been synthetically modified to incorporate the classical ZBG of CA inhibitors i.e. sulfonamide, sulfamate or sulfamide. A summary of these hybrid molecules will also be presented.
Coumarins
Coumarin compounds are abundant secondary metabolites in plants and are found to a lesser Simple coumarins, including coumarin 8 ( Figure 2 ) are highly abundant in several plant species belonging to the taxonomic families Umbelliferae, Rutaceae and Compositae (37) . A recent review of coumarin-based drugs highlights the growing interest in the coumarin compound class to deliver new therapeutics, (38) with potential therapeutic applications driving efforts towards the isolation and the structural characterization of further novel bioactive coumarin derivatives. In recent years it was discovered that NP coumarins inhibit CA enzymes via an alternate and unprecedented mechanism to classical sulfonamides,(39) these findings are described next.
Nature Bank is a unique drug discovery resource that encompasses a diverse collection of >50,000 biota samples of plants, fungi and marine invertebrates collected from Australia, China and Papua New Guinea along with biota extracts, semi-purified fractions and pure compounds (40). A selection of Leionema ellipticum (family Rutaceae) extracts was sourced from Nature Bank and screened using Fourier transform ion cyclotron resonance electrospray ionization mass spectrometry (FTICR ESI MS) for binding to bovine CA II (bCA II) (39) . From this study the NP coumarin, 6-(1S-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one 9 was identified as a ligand for bCA II as it formed a noncovalent complex that could be detected by ESI MS. In follow on studies it was demonstrated that coumarin 9 inhibits a spectrum of human CAs in an Following the findings outlined above we performed a substructure search of the Nature Bank (40) pure compound repository against the bare coumarin scaffold 8. A set of 81 coumarins were identified and from this a subset of 27 coumarins were sourced in sufficient quantity and purity for follow up evaluation as CA inhibitors (48) . These NP coumarins, compounds 11-37 ( Figure   4 ) comprise 24 plant coumarins (compounds 11-34) and three marine coumarins (compounds Table 1 . Data for the simplest coumarin 8 and standard CA inhibitors ( Figure 5 ) is included for development of structure-activity relationships (SAR). 29 and 32 ). This subset of NP coumarins has viable selectivity characteristics that warrant further studies in cell-based models of CA in cancer.
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Phenols
The first single crystal X-ray structure of phenol 38 and a CA protein (hCA II) was reported in 1994 and identified that 38 binds in an unprecedented way within the enzyme active site. The phenols 38-57 have been evaluated for their inhibition of human cytosolic isoforms CA I and II (off-target) and mitochondrial isozymes CA VA and CA VB, These studies showed that several phenolic NPs were selective inhibitors of mycobacterial and 
Polyamines
Polyamines belong to an alkaloid structure class and have been reported from various natural sources including terrestrial and marine animals, plants, fungi and bacteria (2). Two of the simplest polyamines isolated to date include spermine 63 and spermidine 64 ( Figure 10 ). An aromatic group, which is typical for classical CA inhibitors, is absent from these compounds and instead they comprise the hydrophilic mono-or disaccharide fragment directly attached to the ZBG. These NP-ZBG hybrid molecules have been evaluated as CA inhibitors, 
Coumarin-ZBG and steroid-ZBG hybrid molecules
A selection of NP-derived sulfamates are potent inhibitors of the cancer drug target steroid sulfatase (STS) and are being developed as a therapy for hormone-dependent breast cancer (119) . This includes the steroidal sulfamate oestrone-3-O-sulphamate (EMATE) 75 and two coumarin based sulfamates, COUMATE-667 76 and STX-118 77 (Figure 11 ), which at a simpler structural level may also be considered phenolic sulfamates. These NP hybrids, modified with the sulfamate ZBG, are also potent CA inhibitors, Table 5 
Conclusion
Contemporary drug discovery is under increased pressure to identify more suitable small We predict additional NP structures classes will be identified as binding to and perturbing CA function as further research is undertaken.
